Company Filing History:
2 out of 153 
2 out of 23 Years Active: 2025
Title: Innovations of Xiaofen Huang in Vaccine Adjuvants
Introduction
Xiaofen Huang is a notable inventor based in Fujian, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of vaccine adjuvants. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Xiaofen Huang holds 2 patents that focus on the preparation and use of micro-nanoparticle adjuvants for vaccines. His first patent, titled "Preparation of zinc zoledronate micro-nanoparticle adjuvant and use thereof as vaccine adjuvant," discloses a novel adjuvant containing zinc and zoledronic acid, which can enhance vaccine efficacy. The preparation method involves mixed precipitation on a soluble salt solution containing zinc ions, zoledronic acid, and sodium hydroxide. This adjuvant is designed to improve vaccine formulations.
His second patent, "Preparation of zinc risedronate micro/nano adjuvant and use thereof as vaccine adjuvant," pertains to a zinc risedronate micro/nano adjuvant with a sustained-release function. This invention is formed by mineralizing zinc ions and risedronic acid, and it also includes a method for preparing the adjuvant. The patent emphasizes the potential of this adjuvant in vaccine compositions, further contributing to the field of immunology.
Career Highlights
Xiaofen Huang has worked with esteemed institutions such as Xiamen University and Xiamen Innovax Biotech Co., Ltd. His experience in these organizations has allowed him to collaborate with other professionals and contribute to groundbreaking research in vaccine technology.
Collaborations
Xiaofen Huang has collaborated with notable colleagues, including Yike Li and Siyi Chen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Xiaofen Huang's contributions to vaccine adjuvant technology through his patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in vaccine development and public health.